Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile?

Surgery (United States)

Volumn 152, Issue 3 SUPPL., 2012, Pages

  Crippa, Stefano ^a   Partelli, Stefano ^a   Zamboni, Giuseppe ^a   Barugola, Giuliano ^a   Capelli, Paola ^a   Inama, Marco ^a   Bassi, Claudio ^a   Pederzoli, Paolo ^a   Falconi, Massimo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

AGED; CARCINOMA, PANCREATIC DUCTAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE;

EID: 84865221312     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.05.017     Document Type: Article

References (42)

1. M. Wagner, C. Redaelli, and M. Lietz Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 2004 586 594
2. J.M. Winter, J.L. Cameron, and K.A. Campbell 1423 pancreaticoduodenectomies for pancreatic cancer: a single institution experience J Gastrointest Surg 10 2006 1199 1210
3. T.A. Sohn, C.J. Yeo, and J.L. Cameron Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
4. G. Barugola, S. Partelli, and S. Marcucci Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol 16 2009 3316 3322
5. J.E. Lim, M.W. Chien, and C.C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma Ann Surg 237 2003 74 85
6. W. Hartwig, T. Hackert, and U. Hinz Pancreatic cancer in the new millennium: better prediction of outcomes Ann Surg 254 2011 311 319
7. D.D. You, H.G. Lee, J.S. Heo, S.H. Choi, and D.W. Choi Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma J Gastrointest Surg 13 2009 1699 1706
8. C.P. Raut, J.F. Tseng, and C.C. Sun Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
9. S. Reddy, C.L. Wolfgang, and J.L. Cameron Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival Ann Surg 250 2009 282 287
10. S. Partelli, S. Crippa, and G. Barugola Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection Ann Surg Oncol 18 2011 3608 3614
11. T.J. Howard, J.E. Krug, and J. Yu A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer J Gastrointest Surg 10 2006 1338 1345
12. S.P. Cleary, R. Gryfe, and M. Guindi Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors J Am Coll Surg 198 2004 722 731
13. T. Schnelldorfer, A.L. Ware, and M.G. Sarr Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247 2008 456 462
14. C.M. Schmidt, J. Glant, and J.M. Winter Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma Surgery 142 2007 572 578
15. K.F. Kuhlmann, S.M. de Castro, and J.G. Wesseling Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients Eur J Cancer 40 2004 549 558
16. K. Shimada, Y. Sakamoto, T. Sano, and T. Kosuge Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail Surgery 139 2006 288 295
17. J.D. Christein, M.L. Kendrick, C.W. Iqbal, D.M. Nagorney, and M.B. Farnell Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas J Gastrointest Surg 9 2005 922 927
18. K. Shimada, Y. Sakamoto, and S. Nara Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma World J Surg 34 2010 1908 1915
19. C.R. Ferrone, M.F. Brennan, and M. Gonen Pancreatic adenocarcinoma: the actual 5-year survivors J Gastrointest Surg 12 2008 701 706
20. S.M. de Castro, S.S. Biere, and S.M. Lagarde Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas Br J Surg 96 2009 417 423
21. R.A. Abrams, A.M. Lowy, and E.M. O'Reilly Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1751 1756
22. E.P. Kennedy, and C.J. Yeo The case for routine use of adjuvant therapy in pancreatic cancer J Surg Oncol 95 2007 597 603
23. V.J. Picozzi, P.W. Pisters, S.M. Vickers, and S.M. Strasberg Strength of the evidence: adjuvant therapy for resected pancreatic cancer J Gastrointest Surg 12 2008 657 661
24. J.P. Neoptolemos, D.D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
25. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 2007 267 277
26. J.H. Klinkenbijl, J. Jeekel, and T. Stahmound Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776 782
27. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 2008 1019 1026
28. J.P. Neoptolemos, D.D. Stocken, and C. Bassi Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA 304 2010 1073 1081
29. C.H. Crane, G. Varadhachary, and R.A. Wolff The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer Best Pract Res Clin Gastroenterol 20 2006 365 382
30. D.B. Evans, G.R. Varadhachary, and C.H. Crane Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 3496 3502
31. G.R. Varadhachary, R.A. Wolff, and C.H. Crane Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 3487 3495
32. AJCC Cancer Staging Manual 7th ed. 2010 Springer-Verlag New York (NY)
33. R.H. Hrubran, M. Bishop Pitman, and D.S. Klimstra Tumors of the pancreas. AFIP Atlas of Tumor Pathology. 4th Series, Fascicle 6 2007 American Registry of Pathology Washington, DC
34. A. Vincent, J. Herman, R. Schulick, R.H. Hrubran, and M. Goggings Pancreatic cancer Lancet 378 2011 607 620
35. S. Jones, X. Zhang, and D.W. Parsons Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
36. S. Crippa, D. Tamburrino, and S. Partelli Total pancreatectomy: indications, different timing and perioperative and long-term outcomes Surgery 149 2011 79 86
37. J.R. Rodríguez, S.S. Germes, and P.V. Pandharipande Implications and cost of pancreatic leak following distal pancreatic resection Arch Surg 141 2006 361 365
38. G. Veillette, I. Dominguez, and C. Ferrone Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience Arch Surg 143 2008 476 481
39. C. Kamphues, R. Bova, and D. Schricke Postoperative complications deteriorate long-term outcome in pancreatic cancer patients Ann Surg Oncol 19 2012 856 863
40. Y. Hattori, T. Gabata, and Y. Zen Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings Pancreas 39 2010 1263 1270
41. F. Lin, and G. Staerkel Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens Cancer 99 2003 44 50
42. M.A. Eloubeidi, D. Jhala, and D.C. Chhieng Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma Cancer 99 2003 285 292